VeloxCann: Putting the Focus Back on Client Productivity and Drug Discovery

veloxcann banner 2.JPG

The Challenge

Success in industries such as pharmaceutical, cannabis, and food and beverage is measured by the ability to research, adapt, produce, and deliver key findings and products as quickly as possible, while proactively mitigating both regulatory and quality risks simultaneously. Achieving these goals in a constantly evolving environment with pressure to contain costs is a challenging endeavour that requires effective strategies and processes. However, current models for operating laboratories often grapple with inefficiencies that reduce productivity and ultimately drive up costs.

A study revealed that scientists spend up to 25% of their time on non-value-added tasks such as instrument maintenance, paperwork, and inventory management. Another study showed that executives spend an average of 16 hours a week on manual administrative work – the equivalent of two full days a week (Figure 1). Exacerbating factors also include the lack of expertise and time among scientists to pinpoint exact issues that negatively impact operational inefficiencies and identify which equipment and systems need maintenance or upgrading. This impacts productivity in subtle, but substantial ways. The net result of poor productivity is company reluctance to continue making the necessary investments to increase productivity and improve operations.

core vs non core activities.JPG

The Solution

VeloxCann delivers significant cost-savings combined with increased productivity to clients in the cannabis industry, among many others, through two core activities:

1)    Integrating multiple vendor services by incorporating one or more highly trained scientists into your location so that there only needs to be one point of contact between you and your vendors. Managing your entire multivendor laboratory environment, whether it be maintenance or contracts, can be administrative-heavy. Time is money. Time and resources previously tied up with non-core activities is now freed up to focus on discovery and higher-value activities.

2)    Actively benchmarking and managing the performance of both in-house processes and instruments by integrating VeloxCann’s team and system (complementing your existing quality system) to monitor critical attributes. Immediate and long-term cost-savings and value are realized through working side-by-side with your team to proactively identify risks and develop and implement real-time solutions to mitigate costly adverse events. Leveraging our analytics-based approach better equips your team with the ability to make strategic decisions such as scheduled maintenance times to prevent costly downtimes and repositioning under-utilized assets to optimize return on investment. 

The Future 

Powered by over 30 years of experience in a pharmaceutical GMP environment and backed by a robust network of analytical scientists, engineers, and technicians, VeloxCann is seeing increasing applications across industries ranging from cannabis, food and beverage, natural health products, and consumer health care.

On the expansion of client partnerships, VeloxCann looks forward to helping even more clients achieve their operational, financial, and scientific goals during this economic downturn. Our integrative solutions allow your teams to focus on higher-value activities such as product development and sales while we focus on providing best-in-class service and quality to improve and ensure the performance and regulatory compliance of your instruments, processes, and products.

About VeloxCann Inc.

VeloxCann Inc. provides a comprehensive portfolio of customizable services including, but not limited to, corrective and preventative maintenance, on-site and outsourced technicians, qualification and calibration, effective management of analytical instruments and processing equipment, strategic lab and IT consulting, and thorough evaluation of laboratory processes. Additional information is available through www.veloxcann.com or info@veloxcann.com.

Ron Leung